Search Count: 18
 |
Crystal Structure Of Pi3Kalpha Selective Inhibitor Pf-06843195
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.41 Å Release Date: 2021-01-06 Classification: SIGNALING PROTEIN, Transferase Ligands: VXY |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2021-01-06
Ligands: VXY
 |
Crystal Structure Of Pi3Kalpha Selective Inhibitor 11-1575
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.77 Å Release Date: 2021-01-06 Classification: SIGNALING PROTEIN, Transferase Ligands: VY4 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2021-01-06
Ligands: VY4
 |
Crystal Structure Of Pi3Kalpha Inhibitor 10-5429
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.74 Å Release Date: 2021-01-06 Classification: SIGNALING PROTEIN, Transferase Ligands: VY1 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2021-01-06
Ligands: VY1
 |
Crystal Structure Of Pi3Kalpha Inhibitor 4-0686
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.90 Å Release Date: 2021-01-06 Classification: SIGNALING PROTEIN, Transferase Ligands: VYP |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2021-01-06
Ligands: VYP
 |
Covalent Complex Of Sars-Cov Main Protease With N-[(2S)-1-({(2S,3S)-3,4-Dihydroxy-1-[(3S)-2-Oxopyrrolidin-3-Yl]Butan-2-Yl}Amino)-4-Methyl-1-Oxopentan-2-Yl]-4-Methoxy-1H-Indole-2-Carboxamide
Organism: Human sars coronavirus
Method: X-RAY DIFFRACTION Resolution:1.47 Å Release Date: 2020-07-08 Classification: VIRAL PROTEIN Ligands: V2M |
Organism: Human sars coronavirus
Method: X-RAY DIFFRACTION
Release Date: 2020-07-08
Ligands: V2M
 |
Covalent Complex Of Sars-Cov-2 Main Protease With N-[(2S)-1-({(2S,3S)-3,4-Dihydroxy-1-[(3S)-2-Oxopyrrolidin-3-Yl]Butan-2-Yl}Amino)-4-Methyl-1-Oxopentan-2-Yl]-4-Methoxy-1H-Indole-2-Carboxamide
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.41 Å Release Date: 2020-07-08 Classification: VIRAL PROTEIN Ligands: V2M, EDO |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2020-07-08
Ligands: V2M, EDO
 |
Covalent Complex Of Sars-Cov Main Protease With 4-Methoxy-N-[(2S)-4-Methyl-1-Oxo-1-({(2S)-3-Oxo-1-[(3S)-2-Oxopyrrolidin-3-Yl]Butan-2-Yl}Amino)Pentan-2-Yl]-1H-Indole-2-Carboxamide
Organism: Human sars coronavirus
Method: X-RAY DIFFRACTION Resolution:1.38 Å Release Date: 2020-07-08 Classification: VIRAL PROTEIN Ligands: V3D, EDO |
Organism: Human sars coronavirus
Method: X-RAY DIFFRACTION
Release Date: 2020-07-08
Ligands: V3D, EDO
 |
Covalent Complex Of Sars-Cov Main Protease With Ethyl (4R)-4-({N-[(4-Methoxy-1H-Indol-2-Yl)Carbonyl]-L-Leucyl}Amino)-5-[(3S)-2-Oxopyrrolidin-3-Yl]Pentanoate
Organism: Human sars coronavirus
Method: X-RAY DIFFRACTION Resolution:1.45 Å Release Date: 2020-07-08 Classification: VIRAL PROTEIN Ligands: EDO, V34 |
Organism: Human sars coronavirus
Method: X-RAY DIFFRACTION
Release Date: 2020-07-08
Ligands: EDO, V34
 |
Crystal Structure Of Egfr Kinase Domain (L858R, T790M, V948R) In Complex With The Covalent Inhibitor Co-1686
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:3.06 Å Release Date: 2017-10-18 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: 8OV |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2017-10-18
Ligands: 8OV
 |
Crystal Structure Of The Egfr Kinase Domain (L858R, T790M, V948R) In Complex With A Covalent Inhibitor N-[(3R,4R)-4-Fluoro-1-{6-[(1-Methyl-1H-Pyrazol-4-Yl)Amino]-9-(Propan-2-Yl)-9H-Purin-2-Yl}Pyrrolidin-3-Yl]Propanamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.46 Å Release Date: 2017-03-22 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: 8BP, SO4, GOL |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2017-03-22
Ligands: 8BP, SO4, GOL
 |
Crystal Structure Of The Egfr Kinase Domain (L858R, T790M, V948R) In Complex With A Covalent Inhibitor N-[(3R,4R)-4-Fluoro-1-{6-[(3-Methoxy-1-Methyl-1H-Pyrazol-4-Yl)Amino]-9-(Propan-2-Yl)-9H-Purin-2-Yl}Pyrrolidin-3-Yl]Propanamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.33 Å Release Date: 2017-03-22 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: 8AM, SO4, GOL, EDO |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2017-03-22
Ligands: 8AM, SO4, GOL, EDO
 |
Crystal Structure Of The Egfr Kinase Domain (L858R, T790M, V948R) In Complex With 4-(4-{[2-{[(3S)-1-Acetylpyrrolidin-3-Yl]Amino}-9-(Propan-2-Yl)-9H-Purin-6-Yl]Amino}Phenyl)-1-Methylpiperazin-1-Ium
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.82 Å Release Date: 2017-03-22 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: 8BM, SO4, GOL |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2017-03-22
Ligands: 8BM, SO4, GOL
 |
Crystal Structure Of The Egfr Kinase Domain In Complex With 4-(4-{[2-{[(3S)-1-Acetylpyrrolidin-3-Yl]Amino}-9-(Propan-2-Yl)-9H-Purin-6-Yl]Amino}Phenyl)-1-Methylpiperazin-1-Ium
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.53 Å Release Date: 2017-03-22 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: 8BM |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2017-03-22
Ligands: 8BM
 |
Crystal Structure Of The Egfr Kinase Domain (L858R, T790M, V948R) In Complex With A Covalent Inhibitor N-[(3R,4R)-4-Fluoro-1-{6-[(3-Methoxy-1-Methyl-1H-Pyrazol-4-Yl)Amino]-9-Methyl-9H-Purin-2-Yl}Pyrrolidin-3-Yl]Propanamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.58 Å Release Date: 2017-03-22 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: 8BS, SO4, GOL, EDO |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2017-03-22
Ligands: 8BS, SO4, GOL, EDO
 |
Egfr (L858R, T790M, V948R) In Complex With N-{3-[(2-{[4-(4-Methylpiperazin-1-Yl)Phenyl]Amino}-7H-Pyrrolo[2,3-D]Pyrimidin-4-Yl)Oxy]Phenyl}Prop-2-Enamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.52 Å Release Date: 2016-02-03 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: 633, SO4, GOL |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2016-02-03
Ligands: 633, SO4, GOL
 |
Egfr (L858R, T790M, V948R) In Complex With N-[3-({2-[(1-Methyl-1H-Pyrazol-4-Yl)Amino]-7H-Pyrrolo[2,3-D]Pyrimidin-4-Yl}Oxy)Phenyl]Prop-2-Enamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.42 Å Release Date: 2016-02-03 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: 634, SO4, GOL |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2016-02-03
Ligands: 634, SO4, GOL
 |
Egfr (L858R, T790M, V948R) In Complex With 1-[(3R,4R)-3-[({2-[(1-Methyl-1H-Pyrazol-4-Yl)Amino]-7H-Pyrrolo[2,3-D]Pyrimidin-4-Yl}Oxy)Methyl]-4-(Trifluoromethyl)Pyrrolidin-1-Yl]Prop-2-En-1-One
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.15 Å Release Date: 2016-02-03 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: 63A, SO4, GOL |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2016-02-03
Ligands: 63A, SO4, GOL
 |
Egfr (L858R, T790M, V948R) In Complex With 1-{(3R,4R)-3-[5-Chloro-2-(1-Methyl-1H-Pyrazol-4-Ylamino)-7H-Pyrrolo[2,3-D]Pyrimidin-4-Yloxymethyl]-4-Methoxy-Pyrrolidin-1-Yl}Propenone (Pf-06459988)
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.85 Å Release Date: 2016-01-27 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: 630, SO4 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2016-01-27
Ligands: 630, SO4